24 results
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
Board and Cancer Research Executive Team. Prior to GlaxoSmithKline, Dr. Bolno served as Director of Research at Two River LLC, a health care private
S-3
EX-1.2
SQZB
SQZ Biotechnologies Co
12 Nov 21
Shelf registration
12:00am
, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) to conduct the studies that are described in, or the results … other “at the market” or continuous equity transaction.
(uu) Compliance with Health Care Laws. Except as would not, individually or in the aggregate
DEF 14A
342kbw4o
26 Apr 21
Definitive proxy
5:00pm
10-K
mjlhwjnvpjhaajlazgm
18 Mar 21
Annual report
6:31am
424B4
i5pis9wkfgy zbiz
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
qfb8duqe
1 Feb 21
Draft registration statement
12:00am
10-Q
phdlbsa riqbkvrlx
10 Dec 20
Quarterly report
4:46pm
424B4
n11dn46j
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
ya17v1xc7snocyfp
9 Oct 20
IPO registration
4:59pm
S-1
EX-10.7
ol109ubsub
9 Oct 20
IPO registration
4:59pm
DRS/A
7ymtcvw
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
zcoiajr7id232vtqr2
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
dzoss
28 Aug 20
Draft registration statement (amended)
12:00am